Home > Press > More Than 75 Nanotechnology Companies Express Significant and Continuing Concern for Proposed Patent Reform Act
Abstract:
The NanoBusiness Alliance today announced that more than 75 nanotechnology companies have voiced their significant and continuing concern for the Patent Reform Act of 2007 as currently written. The Alliance and its member companies are urging Congress to carefully consider the implications of the proposed patent reform legislation on science-based innovation.
It is the position of the NanoBusiness Alliance that patent reform should strengthen, not weaken, protection for intellectual property and incentives for innovation. However, S. 1145, as drafted, puts science-based innovation at risk. As such, numerous nanotechnology companies have joined with others from a wide variety of industries including high-tech, financial services, manufacturing, med-tech, green-tech, and pharmaceuticals to express strong concern for this bill.
"The NanoBusiness Alliance supports prudent patent reform, however, the legislation as drafted is likely to have significant unintended consequences for entrepreneurs and innovators across a plethora of industries, particularly in those working to commercialize nanotechnology," said Sean Murdock, Executive Director of the NanoBusiness Alliance. "We hope and expect the Senate will address overreaching provisions before moving the bill forward, so we can pass meaningful and beneficial patent reform."
This morning, Mr. Murdock spoke at a press conference with representatives from Monsanto, Masimo, ARYx and Three Arch Partners, and will also be participating in a Senate Staff Briefing this afternoon.
####
About NanoBusiness Alliance
The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Alliance has offices in New York, Chicago, Connecticut and Washington, DC.
For more information, please click here
Contacts:
Schwartz Public Relations
Steven Wright-Mark
212-677-8700 ext. 29
Copyright © Business Wire 2007
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||